A study done on behalf of the devicemakers organization predicted a nearly 11 percent cut for the U.S. medical technology sector due to $2.67 billion in extra taxes.
The study said the tax would put more than 43,000 U.S. jobs at risk by forcing device companies to move production out of the country.
Read the full AdvaMed study.
Related Articles on AdvaMed:
Medical Device Group AdvaMed Spent $366K on Lobbying in 2Q
Study: Medical Device Spending Rising at Half the Rate of U.S. Inflation
Devicemakers Ask Congress to Ease Regulatory Burdens on Industry
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.